Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation. (Q52579549)
Jump to navigation
Jump to search
scientific article published in June 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation. |
scientific article published in June 2007 |
Statements
1 reference
2 references
Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation. (English)
1 reference
Chang-Shi Chen
1 reference
Yu-Chieh Wang
1 reference
Hsiao-Ching Yang
1 reference
Po-Hsien Huang
1 reference
Samuel K Kulp
1 reference
Chih-Cheng Yang
1 reference
Yen-Shen Lu
1 reference
Shigemi Matsuyama
1 reference
Ching-Yu Chen
1 reference
Ching-Shih Chen
1 reference
1 June 2007
1 reference
67
1 reference
11
1 reference
5318-5327
1 reference
1 reference
1 reference